Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
First Trust NYSE Arca Biotechnology Index Fund stock logo
FBT
First Trust NYSE Arca Biotechnology Index Fund
$252.66
+0.9%
$236.28
$161.30
$258.20
$2.87B0.65128,176 shs47,888 shs
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
$5.76
+3.8%
$5.44
$2.92
$6.77
$465.62M0.96305,253 shs182,401 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
First Trust NYSE Arca Biotechnology Index Fund stock logo
FBT
First Trust NYSE Arca Biotechnology Index Fund
-0.33%+2.16%+1.15%+22.26%+50.78%
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
-0.36%-13.28%-7.19%+6.32%+69.72%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
First Trust NYSE Arca Biotechnology Index Fund stock logo
FBT
First Trust NYSE Arca Biotechnology Index Fund
$252.66
+0.9%
$236.28
$161.30
$258.20
$2.87B0.65128,176 shs47,888 shs
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
$5.76
+3.8%
$5.44
$2.92
$6.77
$465.62M0.96305,253 shs182,401 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
First Trust NYSE Arca Biotechnology Index Fund stock logo
FBT
First Trust NYSE Arca Biotechnology Index Fund
-0.33%+2.16%+1.15%+22.26%+50.78%
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
-0.36%-13.28%-7.19%+6.32%+69.72%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
First Trust NYSE Arca Biotechnology Index Fund stock logo
FBT
First Trust NYSE Arca Biotechnology Index Fund
2.65
Moderate Buy$252.66N/A
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
2.40
Hold$9.0056.25% Upside

Current Analyst Ratings Breakdown

Latest FBT, SOPH, PRSM, and KAPE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/21/2026
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
UpgradeHold
7/20/2026
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
Initiated CoverageBuy$12.00
7/17/2026
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
Reiterated RatingSell (D-)
6/15/2026
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
Reiterated RatingBuy$8.00
5/6/2026
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
Reiterated RatingBuy$8.00
(Data available from 7/30/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
First Trust NYSE Arca Biotechnology Index Fund stock logo
FBT
First Trust NYSE Arca Biotechnology Index Fund
N/AN/AN/AN/AN/AN/A
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
$77.27M6.25N/AN/A$0.69 per share8.35
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
First Trust NYSE Arca Biotechnology Index Fund stock logo
FBT
First Trust NYSE Arca Biotechnology Index Fund
N/AN/A21.72N/AN/AN/AN/AN/AN/A
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
-$79M-$0.52N/AN/AN/A-44.48%-62.74%-21.85%8/4/2026 (Estimated)

Latest FBT, SOPH, PRSM, and KAPE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/4/2026Q2 2026
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
-$0.21N/AN/AN/A$21.72 millionN/A
5/5/2026Q1 2026
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
-$0.2325-$0.27-$0.0375-$0.27$20.40 million$21.69 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
First Trust NYSE Arca Biotechnology Index Fund stock logo
FBT
First Trust NYSE Arca Biotechnology Index Fund
$1.170.46%N/AN/AN/A
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
First Trust NYSE Arca Biotechnology Index Fund stock logo
FBT
First Trust NYSE Arca Biotechnology Index Fund
N/AN/AN/A
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
1.05
2.06
1.90

Institutional Ownership

CompanyInstitutional Ownership
First Trust NYSE Arca Biotechnology Index Fund stock logo
FBT
First Trust NYSE Arca Biotechnology Index Fund
N/A
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
31.59%

Insider Ownership

CompanyInsider Ownership
First Trust NYSE Arca Biotechnology Index Fund stock logo
FBT
First Trust NYSE Arca Biotechnology Index Fund
N/A
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
4.88%
CompanyEmployeesShares OutstandingFree FloatOptionable
First Trust NYSE Arca Biotechnology Index Fund stock logo
FBT
First Trust NYSE Arca Biotechnology Index Fund
N/A11.35 millionN/ANot Optionable
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
52083.89 million79.80 millionNot Optionable

Recent News About These Companies

SOPHiA GENETICS (NASDAQ:SOPH) Chairman Sells 24,381 Shares
HC Wainwright Predicts SOPHiA GENETICS Q2 Earnings
HC Wainwright Estimates SOPHiA GENETICS Q2 Earnings

New MarketBeat Followers Over Time

Media Sentiment Over Time

First Trust NYSE Arca Biotechnology Index Fund stock logo

First Trust NYSE Arca Biotechnology Index Fund NYSEARCA:FBT

$252.66 +2.19 (+0.87%)
Closing price 04:10 PM Eastern
Extended Trading
$250.52 -2.14 (-0.85%)
As of 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.

SOPHiA GENETICS stock logo

SOPHiA GENETICS NASDAQ:SOPH

$5.76 +0.21 (+3.78%)
Closing price 04:00 PM Eastern
Extended Trading
$5.82 +0.06 (+0.95%)
As of 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.